8-K
filed February 28, 2023, 6:59 PM ET
ticker NCLH
CIK 0001513761
earnings
confidence high
sentiment positive
materiality 0.80
NCLH reports Q4 net loss $482.5M; guides FY2023 EBITDA $1.8-1.95B on record bookings
Norwegian Cruise Line Holdings Ltd.
2022-FY EPS reported
-$5.41
revenue$4,843,760,000
- Q4 revenue $1.5B, GAAP EPS $(1.14), adjusted EPS $(1.04); occupancy improved to ~87%.
- Revenue per Passenger Cruise Day up ~23% vs 2019; positive adjusted free cash flow ~$71M.
- 2023 outlook: record booked position at higher pricing; occupancy expected ~100% in Q1.
- Adjusted EBITDA guidance $1.8-1.95B; capacity +19% vs 2019 on three newbuilds.
- Net Yield expected +4.75-6.25% vs 2019; cost reduction initiative targets ~15% lower costs.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Norwegian Cruise Line Holdings Ltd. updated its the full year ended December 31, 2022 guidance (initiated).
- Period
- the full year ended December 31, 2022
- Guidance
- initiated
- Result
- reported results
Exact text from the filing
Norwegian Cruise Line Holdings Reports Fourth Quarter and Full Year 2022 Financial Results
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Norwegian Cruise Line Holdings Ltd. reported the fourth quarter ended December 31, 2022 results: revenue $1.5 billion, net income $(482.5) million, EPS $(1.14).
- Period
- the fourth quarter ended December 31, 2022
- Revenue
- $1.5 billion
- Net income
- $(482.5) million
- EPS
- $(1.14)
- Result
- reported results
Exact text from the filing
Total revenue of $1.5 billion, GAAP net loss of $(482.5) million or EPS of $(1.14), Adjusted Net Loss of $(439.7) million or Adjusted EPS of $(1.04), and Adjusted EBITDA of $(41.4) million.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.